Research, Science and Treatments

BREAKING NEWS FROM ASCO: Avelumab Results for Mesothelioma Treatment Released

Dr. Raffit Hassan of the National Cancer Institute, and former chair of the Mesothelioma Applied Research Foundation’s Science Advisory Board, announced results of the Phase 1 clinical trial of avelumab at the most recent ASCO (American Society of Clinical Oncology) meeting in Chicago.
Avelumab, an anti-PD-L1 antibody, works on the basis of boosting the immune system. […]



BREAKING NEWS: Peritoneal Mesothelioma Surgery Specialist to Join University of Chicago Team

As of June 1, Dr. Kiran Turaga, a surgeon from the Medical College of Wisconsin, will be joining Dr. Hedy Kindler and the University of Chicago Medicine’s mesothelioma team.
Dr. Turaga began his career at the Medical College of Wisconsin in 2010. His interest has focused on peritoneal surface malignancies and regional therapies, which includes HIPEC.
HIPEC […]